Skip to main content
Premium Trial:

Request an Annual Quote

GenDx Signs Reseller Agreement With Illumina

NEW YORK (GenomeWeb) – Molecular diagnostics company GenDx has signed an agreement with Illumina Netherlands making GenDx a non-exclusive reseller of Illumina products in certain countries.

Under the terms of the agreement, GenDx can sell Illumina's next-generation sequencing instruments, reagents, and maintenance contracts for the field of HLA sequencing, including GenDx's proprietary HLA-NGSgo reagents and NGSengine software for allelic level HLA typing analysis. GenDx's distribution will take place in Italy, the UK, Germany, Belgium, the Netherlands, Luxembourg, and Finland.

GenDx CEO Wietse Mulder said in a statement that the agreement with Illumina will complement his company's HLA typing offerings and reinforce its leading position in the HLA typing field.

The Scan

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.

Tibetan Study Finds Adaptive Variant Influencing Skin Pigmentation

With a combination of phenotyping and genetic data, researchers document at PNAS a Tibetan-enriched enhancer variant influencing melanin synthesis and ultraviolet light response.

Domestication Linked to Nervous System Genes in Inbred Mouse Strains

Researchers highlighted more than 300 positively selected genes in domesticated mice, including genes linked to nervous system function or behavior in Genome Biology.

ALS Genetic Testing May Be Informative Across Age Ranges, Study Finds

Researchers in the journal Brain identified clinically actionable variants in a significant subset of older ALS patients, prompting them to point to the potential benefits of broader test use.